Oxidized Carotenoid Supplements for Pet Joint Mobility

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Elderly pets often suffer from joint mobility issues, reduced activity levels, and poor coat quality due to age-related conditions such as osteoarthritis, for which existing methods lack effective solutions.

Innovation Solution

Administration of oxidatively transformed carotenoids or their fractionated components in compositions formulated as food products or supplements, which can be administered orally, to improve joint mobility, increase activity levels, and enhance coat quality.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing methods are used to treat osteoarthritis in elderly pets, then joint mobility and activity levels may be maintained, but effective solutions are lacking and treatment outcomes are insufficient

Engineering Contradiction:

Improvetreatment effectivenessVSAvoidavailability of effective solutions

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent transforms carotenoids through oxidative processes to create new compounds with enhanced therapeutic properties. This chemical transformation changes the molecular structure and biological activity of carotenoids, producing oxidized derivatives that demonstrate superior efficacy in treating osteoarthritis-related joint mobility issues and coat quality problems in elderly pets.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The invention combines oxidized carotenoid compounds with fractionated components to create a composite therapeutic composition. This composite approach integrates multiple active constituents that work synergistically to address multiple age-related conditions simultaneously, including joint mobility, activity levels, and coat quality.

Inventive Principle:

Principle #40Composite materials

2Reliability

If oxidatively transformed carotenoids are administered to improve joint mobility and coat quality, then significant improvements are achieved, but the complexity of the composition and administration protocol increases

Engineering Contradiction:

Improveimprovement in joint mobility and coat qualityVSAvoidcomposition formulation complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent fractionates the oxidized carotenoid composition into distinct components with specific therapeutic functions. This segmentation allows for targeted delivery of active constituents and simplifies the administration protocol by providing standardized dosage forms containing optimized combinations of fractionated components.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The oxidized carotenoid composition acts as an intermediary substance that mediates between the administered supplement and the target biological systems. The fractionated components serve as intermediaries that facilitate selective absorption and action on specific tissues, including joint structures and coat follicles, thereby managing the complexity through structured intermediate compounds.

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS10456369B2Methods and compositions for improving the health of animals

Publication Date: 2019.10.29 AVIVAGEN

AI summary

The invention features compositions and methods for the administration of an oxidatively transformed carotenoid, or a component thereof, for improving the health of animals, such as increasing joint mobility, increasing activity, and improving coat quality. In particular, methods for improving the health of animals comprise administering compositions comprising an oligomeric material formed by reaction of oxygen with a carotenoid.